Tissue Regenix Group, announced that John Samuel, Executive Chair, has informed the Board of his intention to step down from both that role and as a board member after 12 years with the Company The Board have appointed Jonathan Glenn, a current non-executive director of Tissue Regenix, to the position of non-executive Chair on an interim basis with immediate effect. Most recently Jonathan was CEO of Consort Medical from 2007 until its recent acquisition by Recipharm AB, and has strong operational experience in the sector. The Board will review the position of Chair in due course and further announcements will be made at the appropriate time.